Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation

Abstract Background MEN1 mutations can inactivate or disrupt menin function and are leading to multiple endocrine neoplasia type 1, a rare heritable tumor syndrome. Case presentation We report on a MEN1 family with a novel heterozygous germline mutation, c.674delG; p.Gly225Aspfs*56 in exon 4 of the...

Full description

Bibliographic Details
Main Authors: Christoph Welsch, Anna Katharina Flügel, Susanne Rondot, Egbert Schulze, Ishani Sircar, Judith Nußbaumer, Jörg Bojunga
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-022-00978-9
_version_ 1829117855644254208
author Christoph Welsch
Anna Katharina Flügel
Susanne Rondot
Egbert Schulze
Ishani Sircar
Judith Nußbaumer
Jörg Bojunga
author_facet Christoph Welsch
Anna Katharina Flügel
Susanne Rondot
Egbert Schulze
Ishani Sircar
Judith Nußbaumer
Jörg Bojunga
author_sort Christoph Welsch
collection DOAJ
description Abstract Background MEN1 mutations can inactivate or disrupt menin function and are leading to multiple endocrine neoplasia type 1, a rare heritable tumor syndrome. Case presentation We report on a MEN1 family with a novel heterozygous germline mutation, c.674delG; p.Gly225Aspfs*56 in exon 4 of the MEN1 gene. Diagnosis and clinical phenotyping of MEN1 was established by laboratory tests, ultrasound, biopsy, MRI imaging and endosonography. The clinical course of the disease was followed in the index patient and her family members for eight years. The mutation was associated with distinct clinical phenotypes in the index patient and three family members harboring p.Gly225Aspfs*56. Family members affected showed primary hyperparathyroidism but variable patterns of associated endocrine tumors, adrenal cortical adenomas, prolactinoma, multifocal pancreatic neuroendocrine tumors, insulinoma and nonsecretory neuroendocrine tumors of the pancreas. The mutation c.674delG; p.Gly225Aspfs*56 leads to a frameshift from codon 225 with early truncation of the menin protein. In silico analysis predicts loss of multiple protein-menin interactions in p.Gly225Aspfs*56, potentially rendering menin insufficient to control cell division and replication. However, no aggressive neuroendocrine tumors were observed in the follow-up of this family. Conclusions We report a novel heterozygous MEN1 frameshift mutation, potentially causing (at least partial) inactivation of menin tumor suppression potential but lacking a genotype–phenotype correlation. Our study highlights the importance of personalized care with appropriate testing and counseling in MEN1 families.
first_indexed 2024-12-13T10:09:53Z
format Article
id doaj.art-c9e0cebbdff3403aa9dbefd8687f8b95
institution Directory Open Access Journal
issn 1472-6823
language English
last_indexed 2024-12-13T10:09:53Z
publishDate 2022-03-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj.art-c9e0cebbdff3403aa9dbefd8687f8b952022-12-21T23:51:28ZengBMCBMC Endocrine Disorders1472-68232022-03-012211810.1186/s12902-022-00978-9Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutationChristoph Welsch0Anna Katharina Flügel1Susanne Rondot2Egbert Schulze3Ishani Sircar4Judith Nußbaumer5Jörg Bojunga6Department of Internal Medicine 1, Goethe-University Hospital FrankfurtDepartment of Internal Medicine 1, Goethe-University Hospital FrankfurtMVZ Labor Dr. Limbach & Kollegen GbRMVZ Labor Dr. Limbach & Kollegen GbRDepartment of Internal Medicine 1, Goethe-University Hospital FrankfurtDepartment of Internal Medicine 1, Goethe-University Hospital FrankfurtDepartment of Internal Medicine 1, Goethe-University Hospital FrankfurtAbstract Background MEN1 mutations can inactivate or disrupt menin function and are leading to multiple endocrine neoplasia type 1, a rare heritable tumor syndrome. Case presentation We report on a MEN1 family with a novel heterozygous germline mutation, c.674delG; p.Gly225Aspfs*56 in exon 4 of the MEN1 gene. Diagnosis and clinical phenotyping of MEN1 was established by laboratory tests, ultrasound, biopsy, MRI imaging and endosonography. The clinical course of the disease was followed in the index patient and her family members for eight years. The mutation was associated with distinct clinical phenotypes in the index patient and three family members harboring p.Gly225Aspfs*56. Family members affected showed primary hyperparathyroidism but variable patterns of associated endocrine tumors, adrenal cortical adenomas, prolactinoma, multifocal pancreatic neuroendocrine tumors, insulinoma and nonsecretory neuroendocrine tumors of the pancreas. The mutation c.674delG; p.Gly225Aspfs*56 leads to a frameshift from codon 225 with early truncation of the menin protein. In silico analysis predicts loss of multiple protein-menin interactions in p.Gly225Aspfs*56, potentially rendering menin insufficient to control cell division and replication. However, no aggressive neuroendocrine tumors were observed in the follow-up of this family. Conclusions We report a novel heterozygous MEN1 frameshift mutation, potentially causing (at least partial) inactivation of menin tumor suppression potential but lacking a genotype–phenotype correlation. Our study highlights the importance of personalized care with appropriate testing and counseling in MEN1 families.https://doi.org/10.1186/s12902-022-00978-9Case reportMEN1Truncating mutationFrameshiftClinical phenotype
spellingShingle Christoph Welsch
Anna Katharina Flügel
Susanne Rondot
Egbert Schulze
Ishani Sircar
Judith Nußbaumer
Jörg Bojunga
Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
BMC Endocrine Disorders
Case report
MEN1
Truncating mutation
Frameshift
Clinical phenotype
title Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
title_full Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
title_fullStr Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
title_full_unstemmed Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
title_short Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation
title_sort distinct clinical phenotypes in a family with a novel truncating men1 frameshift mutation
topic Case report
MEN1
Truncating mutation
Frameshift
Clinical phenotype
url https://doi.org/10.1186/s12902-022-00978-9
work_keys_str_mv AT christophwelsch distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT annakatharinaflugel distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT susannerondot distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT egbertschulze distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT ishanisircar distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT judithnußbaumer distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation
AT jorgbojunga distinctclinicalphenotypesinafamilywithanoveltruncatingmen1frameshiftmutation